Esperion Therapeutics, Inc. (ESPR)

NASDAQ: ESPR · IEX Real-Time Price · USD
2.615
-0.005 (-0.19%)
Mar 28, 2024, 12:54 PM EDT - Market open

Esperion Therapeutics Market Cap

Esperion Therapeutics has a market cap or net worth of $484.84 million as of March 28, 2024. Its market cap has increased by 311.23% in one year.

Market Cap
484.84M
Enterprise Value
943.54M
1-Year Change
311.23%
Ranking
Category
Stock Price
$2.64

Market Cap Chart

Since June 26, 2013, Esperion Therapeutics's market cap has increased from $204.10M to $484.84M, an increase of 137.55%. That is a compound annual growth rate of 8.38%.

History

DateMarket Cap% Change
Mar 26, 2024499.60M3.05%
Mar 25, 2024484.80M14.39%
Mar 22, 2024423.80M8.53%
Mar 21, 2024390.50M-3.65%
Mar 20, 2024405.30M5.30%
Mar 19, 2024384.90M1.45%
Mar 18, 2024379.40M-0.97%
Mar 15, 2024383.10M0.98%
Mar 14, 2024379.40M-6.39%
Mar 13, 2024405.30M6.83%
Mar 12, 2024379.40M-3.29%
Mar 11, 2024392.30M-3.21%
Mar 8, 2024405.30M-3.93%
Mar 7, 2024421.90M-7.32%
Mar 6, 2024455.20M2.50%
Mar 5, 2024444.10M-1.64%
Mar 4, 2024451.50M-4.32%
Mar 1, 2024471.90M1.59%
Feb 29, 2024464.50M-2.33%
Feb 28, 2024475.60M-11.38%
Feb 27, 2024536.70M79.44%
Feb 26, 2024299.10M0.77%
Feb 23, 2024296.80M-0.77%
Feb 22, 2024299.10M0.77%
Feb 21, 2024296.80M-2.62%
View and export this data all the way back to 2013. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
PetIQ 513.28M
UroGen Pharma 510.47M
Orthofix Medical 509.48M
IGM Biosciences 508.50M
Replimune Group 506.45M
Marinus Pharmaceuticals 492.06M
Revance Therapeutics 489.82M
Lexicon Pharmaceuticals 487.55M
Market Cap Rankings